RHI
29
2
T
45
7
LH
52
7
MA
55
-2
SJM
33
4
AMP
69
2
NOC
48
3
EMN
73
4
WU
46
2
GRMN
65
6
STI
55
-8
PCAR
56
3
M
36
2
AAPL
55
6
KO
60
3
MMM
30
4
PVH
67
5
AZO
50
4
PG
60
4
VTR
78
3
RHI
29
2
T
45
7
LH
52
7
MA
55
-2
SJM
33
4
AMP
69
2
NOC
48
3
EMN
73
4
WU
46
2
GRMN
65
6
STI
55
-8
PCAR
56
3
M
36
2
AAPL
55
6
KO
60
3
MMM
30
4
PVH
67
5
AZO
50
4
PG
60
4
VTR
78
3
Financhill
Back

Neurocrine Biosciences Quote, Financials, Valuation and Earnings

My #1 Coin is...

All the details are on the next page.
Buy
68

NBIX
Neurocrine Biosciences

Last Price:
137.49
Seasonality Move:
8.72%

7 Day Trial

ALL ACCESS PASS

$ 7

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

Neurocrine Biosciences Price Quote

$137.49
-1.40 (-1.01%)
(Updated: April 30, 2024 at 6:55 PM ET)

Neurocrine Biosciences Key Stats

Buy
68
Neurocrine Biosciences (NBIX) is a Buy
Day range:
$136.05 - $139.37
52-week range:
$89.04 - $148.37
Dividend yield:
0%
P/E ratio:
56.23
P/S ratio:
7.37
P/B ratio:
6.19%
Volume:
678.4K
Avg. volume:
835.3K
1-year change:
37.46%
Market cap:
$13.8B
Revenue:
$1.9B
EPS:
$2.42

How Much Does Neurocrine Biosciences Make?

Is Neurocrine Biosciences Growing As A Company?

Neurocrine Biosciences Stock Price Performance

What Is Neurocrine Biosciences 52-Week High & Low?

Neurocrine Biosciences Price To Free Cash Flow

Is It Risky To Buy Neurocrine Biosciences?

Is Neurocrine Biosciences Cash Flow Positive?

  • What Is NBIX Cash Flow From Operations?
    Cash flow from operations (TTM) is $389.9M
  • What Is Neurocrine Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $65.3M
  • What Is Neurocrine Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$467.1M

Neurocrine Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    NBIX return on invested capital is 12.09%
  • What Is Neurocrine Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is 9.29%
  • What Is NBIX Return On Equity?
    ROE is a measure of profitability and is 13.17%

Neurocrine Biosciences Earnings Date & Stock Price

Neurocrine Biosciences Competitors

Neurocrine Biosciences Dividend Yield

Data Unavailable

Neurocrine Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 63.64% 1.69%
Revenue: 25.05% -0.62%

Analyst Recommendations

Buy Recommendations: 16
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 153.63
Upside from Last Price: 10.61%

Major Shareholders

  • How many NBIX shares are owned by institutional investors?
    142.6M NBIX shares are owned by institutional investors
  • How many NBIX shares are owned by insiders?
    2.3M NBIX shares are owned by insiders